MOESM3 of Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion

Additional file 3: Figure S7AIII. The treatment with the divalent scFvF7-Fc Ab increases the activation of peptide-stimulated Mart1-specific CD8+ T lymphocytes in terms of IFN-Îł secretion (Exp. II and Exp. III). For details see Legend of Fig. 7a. (PPTX 41 kb)